A noninvasive liquid biopsy service based on next-generation sequencing (NGS) technology that analyzes fetal DNA from maternal blood starting from week 10 of pregnancy in singletons and week 12 in twins. The service provides fetal sex identification and comprehensive chromosomal abnormality screenin...
Manufactured by
South Korea
Global NGS Company, EDGCWe provide the value for a healthy lifestyle by suggesting customized healthcare based on genome information.Through genome analysis, we have provided genetic screening tests to help people predict cancer and diseases and to offer personalized healthcare.We have developed cutting-edge diagnostic solutions that empower individuals to make informed health decisions.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
BioChain (Beijing) Science & Technology. Inc.
China · 4 relevant products
Origin Biotechnology Co., Ltd.
Taiwan · 11 relevant products
Genes 2Me Private Ltd
India · 1 relevant product
55 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 94 closest product alternatives
BioChain (Beijing) Science & Technology. Inc. · China
A comprehensive blood-based screening service designed to detect multiple cancer types simultaneously through gene methylation analysis. This service utilizes advanced NGS technology and is available as a clinical testing service.
Origin Biotechnology Co., Ltd. · Taiwan
A diagnostic service for prenatal screening and diagnosis, focusing on molecular detection techniques for maternal and fetal health assessment.
BioChain (Beijing) Science & Technology. Inc. · China
A targeted blood-based early detection service for specific cancer types utilizing gene methylation biomarkers. This clinical testing service is performed by BioChain's certified medical laboratory.
91 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products